XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Prepaid expenses $ 4,601 $ 2,970
Total current assets 4,601 2,970
Deferred offering costs 222,426
TOTAL ASSETS 227,027 2,970
Current liabilities:    
Accrued expenses 7,900
Total Current Liabilities 285,471 8,756
TOTAL LIABILITIES 285,471 8,756
Commitments and contingencies (Note 7)
Shareholders’ deficit:    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,725,000 shares issued and outstanding [1] 173 173
Additional paid-in capital 24,827 24,827
Share capital receivable (25,000) (25,000)
Accumulated deficit (58,444) (5,786)
Total Shareholders’ deficit (58,444) (5,786) [2]
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT 227,027 2,970
Sponsor [Member]    
Current liabilities:    
Amount due to Sponsor 8,756 8,756
Promissory note - Sponsor $ 268,815
[1] The Company issued 1 share in 2022, 999 shares in 2023 and 1,724,000 shares in January 2024. The company applied the retrospective approach to present the subsequent share issuance in 2024 in the Financial Statements for the year ended December 31, 2023 and six months ended June 30, 2024, respectively. The 1,725,000 shares include up to an aggregate of 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part.
[2] Includes up to an aggregate of 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part.